Gregory Driessens

Company: iTeos Therapeutics

Job title: Program Leader

Seminars:

Engagement of FcγR by a-TIGIT mAbs: Does It Matter & Why? 3:00 pm

• Comparing differentiated mechanisms of action of Fc-live and Fc-dead a-TIGIT drugs • How do Fc-live and Fc-dead a-TIGIT compare in preclinical setting? • How do Fc-live and Fc-dead a-TIGIT compare in patients?Read more

day: Day Two